Downregulation of CD44 Reduces Doxorubicin Resistance of CD44+CD24– breast Cancer Cells [Expression of Concern]
OncoTargets and Therapy · 2026-11 · Volume 19 · 1-1
DOI: 10.2147/ott.s672785 ↗Kurz gefasst
Fachartikel in der Zeitschrift OncoTargets and Therapy, 2026-11. Verfasst von Pham Van Phuc und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Phuc, P. V., Nhan, P. L. P. C., Nhung, T. H. T., Tam, N. T. N., Hoang, N. M. N., Tue, V. G. V., Thuy, D. T. D., & Ngoc, P. K. P. (2026). Downregulation of CD44 Reduces Doxorubicin Resistance of CD44+CD24– breast Cancer Cells [Expression of Concern]. OncoTargets and Therapy, Volume 19, 1-1. https://doi.org/10.2147/ott.s672785
Vancouver
Phuc PV, Nhan PLPC, Nhung THT, Tam NTN, Hoang NMN, Tue VGV, et al. Downregulation of CD44 Reduces Doxorubicin Resistance of CD44+CD24– breast Cancer Cells [Expression of Concern]. OncoTargets and Therapy. 2026;Volume 19:1-1. doi:10.2147/ott.s672785
BibTeX
@article{Phuc2026,
author = {Phuc, Pham Van and Nhan, Phan Lu PLCN Chinh and Nhung, Truong Hai THN and Tam, Nguyen Thanh NTT and Hoang, Nguyen Minh NMH and Tue, Vuong Gia VGT and Thuy, Duong Thanh DTT and Ngoc, Phan Kim PKN},
title = {Downregulation of CD44 Reduces Doxorubicin Resistance of CD44+CD24– breast Cancer Cells [Expression of Concern]},
journal = {OncoTargets and Therapy},
year = {2026},
volume = {Volume 19},
pages = {1--1},
doi = {10.2147/ott.s672785}
}
EUVIMED